{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:38:48Z","timestamp":1790699928048,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.acra.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T20:12:08Z","timestamp":1690920728000},"page":"1828-1835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience"],"prefix":"10.1016","volume":"31","author":[{"given":"Mina S.","family":"Makary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Bozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayssy A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rikabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2023.07.007_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-019-0681-x","article-title":"The epidemiology of hepatocellular carcinoma in the USA","volume":"21","author":"Kim","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.acra.2023.07.007_bib2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"El-Serag","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acra.2023.07.007_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/lt.21738","article-title":"Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation","volume":"15","author":"Onaca","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.acra.2023.07.007_bib5","first-page":"22","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"2","author":"Byam","year":"2013","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.acra.2023.07.007_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12885-016-2894-9","article-title":"Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5\u00a0cm","volume":"16","author":"Su","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acra.2023.07.007_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14694\/EdBook_AM.2014.34.e150","article-title":"Radiation oncology approaches in liver malignancies","author":"Kennedy","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.acra.2023.07.007_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","article-title":"Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"1","author":"Huo","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.acra.2023.07.007_bib11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.acra.2023.07.007_bib12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.acra.2023.07.007_bib13","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00270-016-1426-y","article-title":"Unresectable hepatocellular carcinoma: radioembolization versus chemoembolization: a systematic review and meta-analysis","volume":"39","author":"Lobo","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2023.07.007_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2023.07.007_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cld.499","article-title":"Criteria for liver transplantation in hepatocellular carcinoma","volume":"6","author":"Kulik","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.acra.2023.07.007_bib17","first-page":"469","article-title":"Radioembolization with yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma","volume":"6","author":"Bhangoo","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib18","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3748\/wjg.v25.i32.4614","article-title":"Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions","volume":"25","author":"Inchingolo","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.acra.2023.07.007_bib19","series-title":"Transarterial radioembolization ((TARE))","author":"Hickey","year":"2018"},{"key":"10.1016\/j.acra.2023.07.007_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5306\/wjco.v9.i1.20","article-title":"Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma","volume":"9","author":"Makary","year":"2018","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.acra.2023.07.007_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"New Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.acra.2023.07.007_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.RVI.0000094601.83406.e1","article-title":"Quality improvement guidelines for the reporting and archiving of interventional radiology procedures","volume":"14","author":"Omary","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib25","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.acra.2023.07.007_bib27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2967\/jnumed.117.199752","article-title":"Y Radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort","volume":"59","author":"Abouchaleh","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2023.07.007_bib28","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/cancers12071914","article-title":"Locoregional therapy approaches for hepatocellular carcinoma: recent advances and management strategies","volume":"12","author":"Makary","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2023.07.007_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00268-016-3682-z","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma prior to liver transplantation","volume":"41","author":"Ettorre","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.acra.2023.07.007_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.acra.2023.07.007_bib32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL\u2013EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"56","author":"Llovet","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.acra.2023.07.007_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000508386","article-title":"Yttrium-90 radioembolization therapy for combined hepatocellular and cholangiocarcinoma","volume":"7","author":"Badar","year":"2020","journal-title":"Gastrointest Tumors"},{"key":"10.1016\/j.acra.2023.07.007_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jvir.2019.03.024","article-title":"Locoregional therapy of hepatocellular-cholangiocarcinoma versus hepatocellular carcinoma: a propensity score-matched study","volume":"30","author":"Huang","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib36","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.2147\/OTT.S175715","article-title":"Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials","volume":"11","author":"Casadei Gardini","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.acra.2023.07.007_bib37","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/cam4.5125","article-title":"TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis","volume":"12","author":"Brown","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.acra.2023.07.007_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.27443","article-title":"Prognosis of untreated hepatocellular carcinoma","volume":"61","author":"Giannini","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib39","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s11605-021-05095-x","article-title":"Review of use of Y90 as a bridge to liver resection and transplantation in hepatocellular carcinoma","volume":"25","author":"Qadan","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.acra.2023.07.007_bib40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.31318","article-title":"Liver transplantation following yttrium-90 radioembolization: 15-year experience in 207-patient cohort","volume":"73","author":"Gabr","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2023.07.007_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","article-title":"Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review","volume":"20","author":"Riaz","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib44","first-page":"1387","article-title":"Intra-arterial Infusion of Irinotecan-loaded Drug-elutin Beads (DEBIRI) versus Intravenous Therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.acra.2023.07.007_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2023.07.007_bib46","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2023.07.007_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2023.07.007_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.13220","article-title":"High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microsphere radioembolization","volume":"37","author":"Garin","year":"2017","journal-title":"Liver Int"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633223003574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633223003574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:18:46Z","timestamp":1715134726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633223003574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1076633223003574"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2023.07.007","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}